Role of transforming growth factor β1 (TGF β1) in mediating androgen- induced growth inhibition in human adrenal cortex in vitro

Steroids

Volumn 63, Issue 5-6, 1998, Pages 243-245

  Zatelli, Maria C ^a   Rossi, Roberta ^a   Del Senno, Laura ^a   Degli Uberti, Ettore C ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Dihydrotestosterone; Human adrenal cortex; Quantitative PCR; TGF 1

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; MYC PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ADRENAL CORTEX; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CONFERENCE PAPER; GENE CONTROL; GROWTH INHIBITION; HORMONAL REGULATION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION;

ADRENAL CORTEX; ANDROGENS; BASE SEQUENCE; BLOTTING, NORTHERN; CELL DIVISION; DNA PRIMERS; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0032076656     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(98)00027-0     Document Type: Conference Paper

References (14)

1. 1. Mesiano S, Jaffe RB (1997). Development and functional biology of the primate fetal adrenal cortex. Endocr Rev 18:378-403.
2. 2. Massague J (1990). The transforming growth factor-beta family. Annu Rev Cell Biol 6:597-641.
3. 3. Kingsley DM (1994). The TGF-beta superfamily: New members, new receptors, and new genetic tests of function in different organisms. Gene Dev 8:133-146.
4. 4. Derynck R (1994). TGF-beta-receptor-mediated signaling. Trends Biochem Sci 19:548-553.
5. 5. Markowitz SD, Roberts AB (1996). Tumor suppressor activity of the TGF-beta pathway in human cancers. Cytokine Growth Factor Rev 7:99-102.
6. 6. Szelei J, Jimenez J, Soto AM, Liuzzi MF, Sonnenschein C (1997). Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor. Endocrinology 138: 1406-1412.
7. 7. Siebert PD, Larrick JW (1992). Competitive PCR. Nature (London) 359:557-558.
8. 8. Forster E (1994). Rapid generation of internal standards for competitive PCR by low-stringency primer annealing. Biotechniques 16:1006-1008.
9. 9. Lin HY, Wang XF, Ng-Eaton E, Weinberg RA, Lodish HF (1992). Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase. Cell 68:775-785.
10. 10. Stoica A, Saceda M, Fakhro A, Solomon HB, Fenster BD, Martin MB (1997). The role of transforming growth factor-beta in the regulation of estrogen receptor expression in the MCF-7 breast cancer cell line. Endocrinology 138:1498-1505.
11. 11. Sporn MB, Roberts AB, Wakefield LM, Assoian RK (1986). Transforming growth factor-beta: biologic function and chemical structure. Science (Washington DC) 233:532-534.
12. 12. Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R, Dickson RB (1987). Evidence that transforming growth factor beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48:417-428.
13. 13. Martikainen P, Kyprianou N, Isaacs JT (1988). Effect of transforming growth factor-beta 1 on proliferation and cell death of rat prostatic cells. Endocrinology 127:2963-2968.
14. 14. Kim IY, Kim JH, Zelner DJ, Ahn HJ, Sensibar JA, Lee C (1996). Transforming growth factor-beta 1 is a mediator of androgen-regulated growth arrest in an androgen-responsive prostatic cancer cell line, LNCaP. Endocrinology 137:991-999.